资讯

The Manila Times6 天
Kura Oncology and Kyowa Kirin Announce Submission of New Drug Application for Ziftomenib to FDA
Kura Oncology, Inc. (Nasdaq: KURA, "Kura”), and Kyowa Kirin Co., Ltd. (TSE: 4151, "Kyowa Kirin”), today announced Kura submitted a New Drug Application (NDA) for ziftomenib, a highly selective, ...